Chemotherapy and immunotherapy in metastatic colorectal cancer. Pohlmann PR, Mernaugh RL, Goff LW (2009) N Engl J Med 360: 2134; author reply 2135-6 Can responses to antiretroviral therapy be improved by therapeutic drug monitoring? Haas DW (2006) Clin Infect Dis 42: 1197-9 Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect. Stein CM, Murray JJ, Wood AJ (1999) Clin Chem 45: 1477-84 Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Slaughter JC, Goutte M, Rymer JA, Oranu AC, Schneider JA, Garrett CG, Hagaman D, Vaezi MF (2011) Clin Gastroenterol Hepatol 9: 868-74 Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult. Neuner EA, Ahrens CL, Groszek JJ, Isada C, Vogelbaum MA, Fissell WH, Bhimraj A (2012) J Antimicrob Chemother 67: 1558-60 Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT. Bauer SR, Salem C, Connor MJ, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH (2012) Clin J Am Soc Nephrol 7: 452-7 Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis. Clark JA, Schulman G, Golper TA (2008) Clin J Am Soc Nephrol 3: 736-42 An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JS (2010) Am J Epidemiol 171: 924-31 Biotransformation of tritiated fentanyl in human liver microsomes. Monitoring metabolism using phenylacetic acid and 2-phenylethanol. Tateishi T, Wood AJ, Guengerich FP, Wood M (1995) Biochem Pharmacol 50: 1921-4 Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Connor MJ, Salem C, Bauer SR, Hofmann CL, Groszek J, Butler R, Rehm SJ, Fissell WH (2011) Antimicrob Agents Chemother 55: 557-60 The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. Yankeelov TE, Arlinghaus LR, Li X, Gore JC (2011) Semin Oncol 38: 16-25 The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC, Jiang M, Vranic G, Basford M, Cowan JD, Richardson DM, Robinson MP, Ikizler TA, Ritchie MD, Stein CM, Haas DW (2012) Pharmacogenet Genomics 22: 32-42 In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Zimmermann JJ, Lappas DG (1994) Anesth Analg 79: 670-4 Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Dula AN, Arlinghaus LR, Dortch RD, Dewey BE, Whisenant JG, Ayers GD, Yankeelov TE, Smith SA (2013) Magn Reson Med 70: 216-24 An intervention to improve the timing of vancomycin levels. Melanson SE, Mijailovic AS, Wright AP, Szumita PM, Bates DW, Tanasijevic MJ (2013) Am J Clin Pathol 140: 801-6 What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions. Morrison AP, Melanson SE, Carty MG, Bates DW, Szumita PM, Tanasijevic MJ (2012) Am J Clin Pathol 137: 472-8 An LC-MS assay for the screening of cardiovascular medications in human samples. Dias E, Hachey B, McNaughton C, Nian H, Yu C, Straka B, Brown NJ, Caprioli RM (2013) J Chromatogr B Analyt Technol Biomed Life Sci 937: 44-53 Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer. Nicholson BP, Paul DM, Hande KR, Shyr Y, Meshad M, Cohen A, Johnson DH (2000) Clin Breast Cancer 1: 136-43; discussion 144 Ultrasound Measurement of Vascular Density to Evaluate Response to Anti-Angiogenic Therapy in Renal Cell Carcinoma. Rojas JD, Papadopoulou V, Czernuszewicz TJ, Rajamahendiran RM, Chytil A, Chiang YC, Chong DC, Bautch VL, Rathmell WK, Aylward S, Gessner RC, Dayton PA (2019) IEEE Trans Biomed Eng 66: 873-880 Laboratory assays in renal failure: therapeutic drug monitoring. Fissell WH (2014) Semin Dial 27: 614-7 Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis. Ryder KM, Tanner SB, Carbone L, Williams JE, Taylor HM, Bush A, Pintea V, Watsky MA (2010) J Bone Miner Metab 28: 233-9 Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin. Cox ZL, Nelsen CL, Waitman LR, McCoy JA, Peterson JF (2011) Am J Health Syst Pharm 68: 624-32 Oral retinoids and plasma lipids. Lilley JS, Linton MF, Fazio S (2013) Dermatol Ther 26: 404-10 Methodological issues in the investigation of ginseng as an intervention for fatigue. Elam JL, Carpenter JS, Shu XO, Boyapati S, Friedmann-Gilchrist J (2006) Clin Nurse Spec 20: 183-9 False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review. Taguchi K, Ohmura T, Ohya Y, Horio M, Furukawa K, Jono H, Inomata Y, Saito H (2014) Exp Clin Transplant 12: 474-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.